Dementia: New Alzheimer's drug 'could slow rate at which disease progresses' Scientists believe they could be on the cusp of a breakthrough, after a drugs company said it had the first treatment of its kind for Alzheimer's.
The drug, which is called aducanumab, cannot cure it but Biogen says it slows down the rate at which it progresses, essentially meaning people stay more like themselves for longer.
This came as a surprise as the company had suspended the drug trial in March 2019 because of disappointing results. BBC News
No comments:
Post a Comment